Dr. Khan research interests involve mechanism-based drug repurposing in cardiovascular complications of diabetes. Waheed has recently published and profiled in Journal “Diabetes” world’s first single cell transcriptome of the whole aorta in diabetes that is the basis of his ongoing research program.

Wilson is a researcher within the diabetes research team of Prof. Hardikar and Dr. Joglekar at Western Sydney University (WSU) and recipient of the T1D breakthrough fellowship. He has also been supported via ADS Lindsey Baudinet Rising Star Award and WSU Research Theme Grant Assistance for mechanistic research on non-coding(nc-)RNA.

Cameron Evans, PhD student at the Kolling Institute, University of Sydney, explores repurposing TGA-approved drugs for diabetic foot ulcers and peripheral artery disease, using animal models, human tissue, and cells. He is jointly supervised by A/Prof Sarah Glastras and Prof Gemma Figtree.

Dr Min, BMed, PhD, is the Scientific Head of the Greg Brown Diabetes & Endocrine Research Laboratory at the Charles Perkins Centre, a Senior Lecturer at the University of Sydney, and a Principal Scientist in the Department of Endocrinology at Royal Prince Alfred Hospital.

Miss Isabelle El-Azzi is a PhD candidate with the Diabetes and Islet Biology Group at Western Sydney University.

Ashraf Broury is a PhD candidate at Monash University, researching antigen-specific regulatory T cell therapy for Type 1 Diabetes. As part of the Ooi Lab, his work focuses on TCR discovery as a method to advance precision immunotherapies for autoimmune diseases.